CALR and myeloproliferative neoplasm: In a study of MPN patients (n = 113) carrying the mutant CRT, the KDEL‐lacking mutant CRT was secreted into their plasma, with a mean concentration of ~24.6 ng/ml (range 0–156.5 ng/ml).58